DCGI approves three COVID vaccines for kids aged above five years
The approval has been granted to Covaxin, ZyCov-D and Corbevax
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Lifesciences
Zydus announces publication of “Dream-ND” and “Dream-D” phase-III trials of Desidustat in “American…
Desidustat’s development is based on the Nobel Prize in Medicine winning science on discoveries of the oxygen-sensing mechanism of…
Zydus Lifesciences receives final approval from US FDA for Cyanocobalamin injection
The injection is used to treat and prevent lack of vitamin B12 that may be caused due to pernicious anaemia, certain diseases,…
Zydus to supply Sagent’s Caffeine Citrate Oral Solution from Jarod
This product is indicated for the short-term treatment of a breathing problem (Apnea) in pre-mature infants
‘The Lancet’ publishes phase-III data of ZyCoV-D
The results of the phase-I part of the phase-I/II clinical trial have already been published in the e-Clinical Medicine Journal of…
Zydus receives PAS approval from US FDA for Mycophenolate Mofetil for injection
The injection will be manufactured at the group’s injectables manufacturing facility at Jarod near Vadodara in Gujarat
Zydus receives final approval from US FDA for Colestipol Hydrochloride tablets
Colestipol hydrochloride tablets are indicated as adjunctive therapy to diet for the reduction of elevated serum total and LDL-C…
Sentynl Therapeutics and BridgeBio Pharma announce asset purchase agreement for Nulibry
Under the terms of the agreement, Sentynl will acquire global rights to Nulibry, and will be responsible for its ongoing…
Zydus receives DCGI approval for Oxemia to treat anaemia in CKD patients
OxemiaTM (Desidustat) is an oral tablet formulation which is the first-in-India alternative to injectable…
Cadila Healthcare renamed as Zydus Lifesciences
Zydus unveils its ‘innovation and care’-centric corporate brand identity